Five Proposals to Stop the Games and Encourage a Robust Biosimilar Market
FDA Request for Comments on Biologics Marketplace, 2018
1 Pages Posted: 12 Oct 2018
Date Written: September 14, 2018
This short comment offers five proposals that could encourage a more robust market for biosimilars, targeting REMS denials, non-REMS denials, citizen petitions, and disparagement, and discussing coordination with the FTC.
Keywords: FDA, competition, antitrust, REMS, citizen petitions, FTC
JEL Classification: I18, K21, L40, L41, L43, L65, O34, O38
Suggested Citation: Suggested Citation